Vonage Pharma

Edit Content
Vonage Pharma Logo white

Buprenorphine Base API – High Purity, GMP Certified

Buprenorphine is a partial opioid agonist and is used to control severe pain that does not respond to other treatments and requires opioid drugs. It is also used in the maintenance phase of opioid addiction treatment.

CAS No: 52485-79-7 | Molecular Formula: C29H41NO4 | Molecular Weight: 467.64 g/mol

Stock Code : 90e8b8ff6b3c Category :

Overview: Buprenorphine Base is a potent medication designed for effective pain management and the treatment of opioid use disorder. As a semisynthetic opioid, it provides significant analgesic effects while minimizing the risks associated with traditional full agonist opioids.

Key Features & Benefits of Buprenorphine Base

GMP Certified – Produced under rigorous quality controls
COA & DMF Available – Comprehensive regulatory documentation
99%+ Purity – Premium pharmaceutical-grade material
Bulk Supply Ready – Worldwide shipping with prompt delivery
Storage: [below 30°C] | Shipping: [below 30°C]

Regulatory & Compliance

Pharmacopoeia Standards: USP/EP/BP/JP
DMF & COA Available upon request

Technical Specifications

Parameter Details
CAS No. 52485-79-7
Molecular Formula C29H41NO4
Molecular Weight 467.64 g/mol
Indications Opioid receptor partial agonist; analgesic
Storage Temp. Store at controlled room temperature (below 30°C)
Shipping Temp. Ambient or as required
Appearance White to Off-White Crystalline Powder
Chemical Name Buprenorphine Base

Looking for Bulk Orders? Request a quote today for competitive pricing!

Buprenorphine Base drum

Buprenorphine is available in several formulations, including:

Indications of Buprenorphine Base

  • Management of severe acute and chronic pain where other treatments are inadequate.
  • Treatment of opioid use disorder as part of a comprehensive recovery program that includes counseling and behavioral therapy.

Dosage and Administration

It can be administered via various routes, including sublingual tablets and transdermal patches. The sublingual tablets should be placed under the tongue until fully dissolved.

Contraindications

  • Hypersensitivity to buprenorphine or any components of the formulation.
  • Significant respiratory depression or acute asthma in an unmonitored setting.

Warnings and Precautions

  • Cardiovascular disease
  • Hepatic impairment
  • History of seizures or respiratory issues

Side Effects

Common side effects may include:

  • Nausea
  • Constipation
  • Dizziness
  • Headache

Manufacturer: Vonage Pharma (Former Pluvia Endo) manufactures Buprenorphine Base, ensuring high-quality standards and compliance with regulatory requirements.

For more information from Vonage Pharma (Former Pluvia Endo) or to place an order, don’t hesitate to contact us today!

FAQs

What is Buprenorphine Base API used for?

Buprenorphine Base API is a critical pharmaceutical ingredient used in medications to manage moderate to severe pain and treat opioid addiction. It offers a safer alternative with a lower risk of overdose.

Do you provide COA and regulatory documents?

Yes, we provide a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and Drug Master File (DMF) support upon request.

What is the minimum order quantity (MOQ)?

The minimum order quantity (MOQ) varies based on region and customer requirements. Please contact us for detailed information.

How is the product shipped and stored?

Buprenorphine Base API is shipped under controlled conditions to ensure stability and should be stored at temperatures below 30°C.

Do you supply globally?

Yes, we supply pharmaceutical manufacturers worldwide, complying with regional regulatory standards.

We understand the complexities and challenges you face in the healthcare industry. That’s why we’re dedicated to providing innovative solutions and insightful knowledge to help you achieve your goals.

Your input is crucial in helping us understand your needs and deliver the most relevant support:

Related Products

Scroll to Top